img

Global Pneumonia Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Pneumonia Market Research Report 2024

Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affects over 450 million people across the globe and results in four million deaths every year. The global pneumonia therapeutics market is projected to expand at a significant pace during the forecast period, due to increase in the number of cases of pneumonia and advancement in treatments. Moreover, growing awareness about pneumonia treatment among patients, rising demand for treatment, increasing incidence of pneumonia, and improvement in diagnosis methods are promoting the growth of the global pneumonia therapeutics market.
According to MRAResearch’s new survey, global Pneumonia market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pneumonia market research.
Increase in number of resistant strains and high rate of mortality & morbidity associated with pneumococcal infection have led to increased preference for prevention therapy. The high preventive rates of these vaccines, 5-year immunization schedule, and increasing support for vaccination by various regulatory agencies are expected to provide lucrative growth opportunities.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Pneumonia market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Pfizer
GlaxoSmithKline(GSK)
Merck
Novartis
Sanofi
Eli Lilly
Segment by Type
Drugs
Vaccines
Oxygen Therapy

Segment by Application


Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Pneumonia report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pneumonia Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Drugs
1.2.3 Vaccines
1.2.4 Oxygen Therapy
1.3 Market by Application
1.3.1 Global Pneumonia Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pneumonia Market Perspective (2018-2033)
2.2 Pneumonia Growth Trends by Region
2.2.1 Global Pneumonia Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Pneumonia Historic Market Size by Region (2018-2023)
2.2.3 Pneumonia Forecasted Market Size by Region (2024-2033)
2.3 Pneumonia Market Dynamics
2.3.1 Pneumonia Industry Trends
2.3.2 Pneumonia Market Drivers
2.3.3 Pneumonia Market Challenges
2.3.4 Pneumonia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pneumonia Players by Revenue
3.1.1 Global Top Pneumonia Players by Revenue (2018-2023)
3.1.2 Global Pneumonia Revenue Market Share by Players (2018-2023)
3.2 Global Pneumonia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pneumonia Revenue
3.4 Global Pneumonia Market Concentration Ratio
3.4.1 Global Pneumonia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pneumonia Revenue in 2022
3.5 Pneumonia Key Players Head office and Area Served
3.6 Key Players Pneumonia Product Solution and Service
3.7 Date of Enter into Pneumonia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pneumonia Breakdown Data by Type
4.1 Global Pneumonia Historic Market Size by Type (2018-2023)
4.2 Global Pneumonia Forecasted Market Size by Type (2024-2033)
5 Pneumonia Breakdown Data by Application
5.1 Global Pneumonia Historic Market Size by Application (2018-2023)
5.2 Global Pneumonia Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Pneumonia Market Size (2018-2033)
6.2 North America Pneumonia Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Pneumonia Market Size by Country (2018-2023)
6.4 North America Pneumonia Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pneumonia Market Size (2018-2033)
7.2 Europe Pneumonia Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Pneumonia Market Size by Country (2018-2023)
7.4 Europe Pneumonia Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pneumonia Market Size (2018-2033)
8.2 Asia-Pacific Pneumonia Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Pneumonia Market Size by Region (2018-2023)
8.4 Asia-Pacific Pneumonia Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pneumonia Market Size (2018-2033)
9.2 Latin America Pneumonia Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Pneumonia Market Size by Country (2018-2023)
9.4 Latin America Pneumonia Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pneumonia Market Size (2018-2033)
10.2 Middle East & Africa Pneumonia Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Pneumonia Market Size by Country (2018-2023)
10.4 Middle East & Africa Pneumonia Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Pneumonia Introduction
11.1.4 Pfizer Revenue in Pneumonia Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 GlaxoSmithKline(GSK)
11.2.1 GlaxoSmithKline(GSK) Company Detail
11.2.2 GlaxoSmithKline(GSK) Business Overview
11.2.3 GlaxoSmithKline(GSK) Pneumonia Introduction
11.2.4 GlaxoSmithKline(GSK) Revenue in Pneumonia Business (2018-2023)
11.2.5 GlaxoSmithKline(GSK) Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Pneumonia Introduction
11.3.4 Merck Revenue in Pneumonia Business (2018-2023)
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Pneumonia Introduction
11.4.4 Novartis Revenue in Pneumonia Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Pneumonia Introduction
11.5.4 Sanofi Revenue in Pneumonia Business (2018-2023)
11.5.5 Sanofi Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Pneumonia Introduction
11.6.4 Eli Lilly Revenue in Pneumonia Business (2018-2023)
11.6.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Pneumonia Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Drugs
Table 3. Key Players of Vaccines
Table 4. Key Players of Oxygen Therapy
Table 5. Global Pneumonia Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Pneumonia Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Pneumonia Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Pneumonia Market Share by Region (2018-2023)
Table 9. Global Pneumonia Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Pneumonia Market Share by Region (2024-2033)
Table 11. Pneumonia Market Trends
Table 12. Pneumonia Market Drivers
Table 13. Pneumonia Market Challenges
Table 14. Pneumonia Market Restraints
Table 15. Global Pneumonia Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Pneumonia Market Share by Players (2018-2023)
Table 17. Global Top Pneumonia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia as of 2022)
Table 18. Ranking of Global Top Pneumonia Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Pneumonia Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pneumonia Product Solution and Service
Table 22. Date of Enter into Pneumonia Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pneumonia Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Pneumonia Revenue Market Share by Type (2018-2023)
Table 26. Global Pneumonia Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Pneumonia Revenue Market Share by Type (2024-2033)
Table 28. Global Pneumonia Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Pneumonia Revenue Market Share by Application (2018-2023)
Table 30. Global Pneumonia Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Pneumonia Revenue Market Share by Application (2024-2033)
Table 32. North America Pneumonia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Pneumonia Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Pneumonia Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Pneumonia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Pneumonia Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Pneumonia Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Pneumonia Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Pneumonia Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Pneumonia Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Pneumonia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Pneumonia Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Pneumonia Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Pneumonia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Pneumonia Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Pneumonia Market Size by Country (2024-2033) & (US$ Million)
Table 47. Pfizer Company Detail
Table 48. Pfizer Business Overview
Table 49. Pfizer Pneumonia Product
Table 50. Pfizer Revenue in Pneumonia Business (2018-2023) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. GlaxoSmithKline(GSK) Company Detail
Table 53. GlaxoSmithKline(GSK) Business Overview
Table 54. GlaxoSmithKline(GSK) Pneumonia Product
Table 55. GlaxoSmithKline(GSK) Revenue in Pneumonia Business (2018-2023) & (US$ Million)
Table 56. GlaxoSmithKline(GSK) Recent Development
Table 57. Merck Company Detail
Table 58. Merck Business Overview
Table 59. Merck Pneumonia Product
Table 60. Merck Revenue in Pneumonia Business (2018-2023) & (US$ Million)
Table 61. Merck Recent Development
Table 62. Novartis Company Detail
Table 63. Novartis Business Overview
Table 64. Novartis Pneumonia Product
Table 65. Novartis Revenue in Pneumonia Business (2018-2023) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Sanofi Company Detail
Table 68. Sanofi Business Overview
Table 69. Sanofi Pneumonia Product
Table 70. Sanofi Revenue in Pneumonia Business (2018-2023) & (US$ Million)
Table 71. Sanofi Recent Development
Table 72. Eli Lilly Company Detail
Table 73. Eli Lilly Business Overview
Table 74. Eli Lilly Pneumonia Product
Table 75. Eli Lilly Revenue in Pneumonia Business (2018-2023) & (US$ Million)
Table 76. Eli Lilly Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pneumonia Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Pneumonia Market Share by Type: 2022 VS 2033
Figure 3. Drugs Features
Figure 4. Vaccines Features
Figure 5. Oxygen Therapy Features
Figure 6. Global Pneumonia Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Pneumonia Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Pneumonia Report Years Considered
Figure 12. Global Pneumonia Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Pneumonia Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Pneumonia Market Share by Region: 2022 VS 2033
Figure 15. Global Pneumonia Market Share by Players in 2022
Figure 16. Global Top Pneumonia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Pneumonia Revenue in 2022
Figure 18. North America Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Pneumonia Market Share by Country (2018-2033)
Figure 20. United States Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Pneumonia Market Share by Country (2018-2033)
Figure 24. Germany Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Pneumonia Market Share by Region (2018-2033)
Figure 32. China Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Pneumonia Market Share by Country (2018-2033)
Figure 40. Mexico Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Pneumonia Market Share by Country (2018-2033)
Figure 44. Turkey Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Pneumonia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Pfizer Revenue Growth Rate in Pneumonia Business (2018-2023)
Figure 47. GlaxoSmithKline(GSK) Revenue Growth Rate in Pneumonia Business (2018-2023)
Figure 48. Merck Revenue Growth Rate in Pneumonia Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Pneumonia Business (2018-2023)
Figure 50. Sanofi Revenue Growth Rate in Pneumonia Business (2018-2023)
Figure 51. Eli Lilly Revenue Growth Rate in Pneumonia Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries